Michael Platt, MD
Psychiatry · South Bend, INNPI 1588801500
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,580 of the $11,614 with a category attached, or 82.5%. It is spread thinly across 22 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 275 payments — averaging $42.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$3K
- AbbVie$2K
- Neurocrine Biosciences, Inc.$1K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$856
- Axsome Therapeutics, Inc.$855
- Alkermes, Inc.$810
- plus $3K from 16 others
What the payments were for
- Consulting fees$1,84016%
- Food & beverage$9,58082%
- Education$1942%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 24 | $2,783 |
| AbbVie(2 entities) | 87 | $1,856 |
| Neurocrine Biosciences, Inc. | 19 | $1,215 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 10 | $856 |
| Axsome Therapeutics, Inc. | 19 | $855 |
| Alkermes, Inc. | 27 | $810 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $518 |
| Boehringer Ingelheim | 6 | $502 |
| Janssen Scientific Affairs, LLC | 5 | $483 |
| Corium, LLC | 5 | $437 |
| Otsuka America Pharmaceutical, Inc. | 17 | $342 |
| Teva Pharmaceuticals USA, Inc. | 7 | $257 |
| Johnson & Johnson | 10 | $144 |
| Vanda Pharmaceuticals Inc. | 5 | $128 |
| Livanova USA, Inc. | 1 | $123 |
| Lundbeck LLC | 6 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $81 |
| Sunovion Pharmaceuticals Inc. | 3 | $43 |
| Avanir Pharmaceuticals, Inc. | 2 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Indivior Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$847
- ARISTADA$424
- COBENFY$376
- VRAYLAR$345
- Azstarys$256
- Auvelity$250
- CAPLYTA$249
- INVEGA SUSTENNA$238
- REJOYN$210
- SPRAVATO$123
- VNS - Symmetry$123
- INVEGA TRINZA$116
- REXULTI$110
- LYBALVI$106
How this compares
$11,614 in reported general payments places this provider in the 90th percentile of 514 psychiatry providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 162 | $527,570 |
| IngrezzaValbenazine Tosylate | 50 | $404,730 |
| VraylarCariprazine Hcl | 113 | $161,630 |
| Abilify AsimtufiiAripiprazole | 20 | $118,988 |
| Abilify MaintenaAripiprazole | 32 | $93,050 |
| AuvelityDextromethorphan Hbr/Bupropion | 73 | $86,159 |
| AustedoDeutetrabenazine | 14 | $80,016 |
| AristadaAripiprazole Lauroxil | 24 | $76,475 |
| RexultiBrexpiprazole | 44 | $64,897 |
| BelsomraSuvorexant | 108 | $49,861 |
| TrintellixVortioxetine Hydrobromide | 56 | $37,756 |
| Paliperidone ErPaliperidone | 124 | $33,601 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 177 | $32,253 |
| VivitrolNaltrexone Microspheres | 16 | $28,928 |
| CobenfyXanomeline Tart/Trospium Chlor | 13 | $22,538 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $144 | $527,570162 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $1,215 | $404,73050 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Asimtufii, Abilify Maintena, Rexulti | $342 | $276,93596 claims |
| AbbVieVraylar | $1,856 | $161,630113 claims |
| Alkermes, Inc.Aristada, Vivitrol, Lybalvi | $810 | $122,55051 claims |
| Axsome Therapeutics, Inc.Auvelity | $855 | $86,15973 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $257 | $80,01614 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $81 | $49,66987 claims |
| E.r. Squibb & Sons, L.L.C.Cobenfy | $2,783 | $22,53813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 514 psychiatry providers in Indiana.
Other psychiatry in South Bend
- John HaskinSouth Bend$16K
- Erik ThordarsonSouth Bend$12K
- Steven PaulCarmel$2.9M
- Jay FawverAngola$1.4M
- Suhayl NasrMichigan City$739K
- Christopher BojrabCarmel$713K
- Joseph FanelliMunster$443K
- Eric JaggersJeffersonville$260K
- Larry LambertsonFort Wayne$208K
- Louis CadyNewburgh$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.